These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38619892)

  • 1. Chiral Iridium-Based TLD-1433 Analogues: Exploration of Enantiomer-Dependent Behavior in Photodynamic Cancer Therapy.
    Wang W; Wang L; Zhang Y; Shi Y; Zhang R; Chen L; Shi Z; Yuan S; Li X; He C; Li X
    Inorg Chem; 2024 Apr; 63(17):7792-7798. PubMed ID: 38619892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into the anticancer photodynamic activity of Ir(III) and Ru(II) polypyridyl complexes bearing β-carboline ligands.
    Sanz-Villafruela J; Bermejo-Casadesus C; Zafon E; Martínez-Alonso M; Durá G; Heras A; Soriano-Díaz I; Giussani A; Ortí E; Tebar F; Espino G; Massaguer A
    Eur J Med Chem; 2024 Oct; 276():116618. PubMed ID: 38972079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclometalated iridium(III) tetrazine complexes for mitochondria-targeted two-photon photodynamic therapy.
    Tan Z; Lin M; Liu J; Wu H; Chao H
    Dalton Trans; 2024 Aug; 53(31):12917-12926. PubMed ID: 39028267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards efficient Ir(III) anticancer photodynamic therapy agents by extending π-conjugation on N^N ligands.
    Sanz-Villafruela J; Bermejo-Casadesús C; Martínez-Alonso M; Moro A; Lima JC; Massaguer A; Espino G
    Dalton Trans; 2024 Jul; 53(27):11393-11409. PubMed ID: 38899369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing the tumor cell selectivity of a rhodamine-decorated iridium(III) complex by conjugating with indomethacin for COX-2 targeted photodynamic therapy.
    Liu C; Xiang J; Xiang C; Li H
    Bioorg Chem; 2021 Sep; 114():105142. PubMed ID: 34243072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclometalated iridium(iii) complexes for mitochondria-targeted combined chemo-photodynamic therapy.
    Qin WW; Pan ZY; Cai DH; Li Y; He L
    Dalton Trans; 2020 Mar; 49(11):3562-3569. PubMed ID: 32123890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-wavelength triggered iridium(III) complex nanoparticles for photodynamic therapy against hypoxic cancer.
    Liu S; Wang Z; Wu Z; Chen H; Zhu D; Li G; Yan M; Bryce MR; Chang Y
    Chem Commun (Camb); 2024 Sep; 60(73):9938-9941. PubMed ID: 39171567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Photodynamic and Photochemotherapeutic Platinum-Iridium Charge-Transfer Conjugate for Anticancer Therapy.
    Shi H; Carter OWL; Ponte F; Imberti C; Gomez-Gonzalez MA; Cacho-Nerin F; Quinn PD; Parker JE; Sicilia E; Huang H; Sadler PJ
    Angew Chem Int Ed Engl; 2024 Jun; 63(23):e202400476. PubMed ID: 38656762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bombesin-Targeted Delivery of β-Carboline-Based Ir(III) and Ru(II) Photosensitizers for a Selective Photodynamic Therapy of Prostate Cancer.
    Sanz-Villafruela J; Bermejo-Casadesús C; Riesco-Llach G; Iglesias M; Martínez-Alonso M; Planas M; Feliu L; Espino G; Massaguer A
    Inorg Chem; 2024 Oct; 63(41):19140-19155. PubMed ID: 39361042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ir(III) and Ru(II) Complexes in Photoredox Catalysis and Photodynamic Therapy: A New Paradigm towards Anticancer Applications.
    Raza MK; Noor A; Samantaray PK
    Chembiochem; 2021 Dec; 22(23):3270-3272. PubMed ID: 34558773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of pH-responsive cyclometalated iridium(III) complex and its application in the selective killing of cancerous cells.
    Yang P; Zhang S; Wang K; Qi H
    Dalton Trans; 2021 Nov; 50(46):17338-17345. PubMed ID: 34788356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-Chemiluminescence-Triggered Ir(III) Complex Photosensitizer for Photodynamic Therapy against Hypoxic Tumor.
    Liu S; Chen H; Wu Q; Sun Y; Pei Y; Wang Z; Zhu D; Li G; Bryce MR; Chang Y
    Inorg Chem; 2024 Sep; 63(35):16404-16417. PubMed ID: 39150967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. π-Expansive Heteroleptic Ruthenium(II) Complexes as Reverse Saturable Absorbers and Photosensitizers for Photodynamic Therapy.
    Wang L; Yin H; Jabed MA; Hetu M; Wang C; Monro S; Zhu X; Kilina S; McFarland SA; Sun W
    Inorg Chem; 2017 Mar; 56(6):3245-3259. PubMed ID: 28263079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mitochondria-targeting dinuclear Ir-Ru complex as a synergistic photoactivated chemotherapy and photodynamic therapy agent against cisplatin-resistant tumour cells.
    Zhang C; Guan R; Liao X; Ouyang C; Rees TW; Liu J; Chen Y; Ji L; Chao H
    Chem Commun (Camb); 2019 Oct; 55(83):12547-12550. PubMed ID: 31576841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ruthenium(II) Conjugates of Boron-Dipyrromethene and Biotin for Targeted Photodynamic Therapy in Red Light.
    Paul S; Kundu P; Bhattacharyya U; Garai A; Maji RC; Kondaiah P; Chakravarty AR
    Inorg Chem; 2020 Jan; 59(1):913-924. PubMed ID: 31825210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trifluoromethyl-Substituted Iridium(III) Complexes: From Photophysics to Photooxidation of a Biological Target.
    Bevernaegie R; Marcélis L; Laramée-Milette B; De Winter J; Robeyns K; Gerbaux P; Hanan GS; Elias B
    Inorg Chem; 2018 Feb; 57(3):1356-1367. PubMed ID: 29336560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Near-infrared-emitting heteroleptic cationic iridium complexes derived from 2,3-diphenylbenzo[g]quinoxaline as in vitro theranostic photodynamic therapy agents.
    Wang L; Yin H; Cui P; Hetu M; Wang C; Monro S; Schaller RD; Cameron CG; Liu B; Kilina S; McFarland SA; Sun W
    Dalton Trans; 2017 Jun; 46(25):8091-8103. PubMed ID: 28604869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticancer activity and mechanism studies of photoactivated iridium(III) complexes toward lung cancer A549 cells.
    Zhou L; Li J; Chen J; Yao X; Zeng X; Liu Y; Wang Y; Wang X
    Dalton Trans; 2024 Sep; 53(36):15176-15189. PubMed ID: 39221457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuning the organelle specificity and cytotoxicity of iridium(III) photosensitisers for enhanced phototheranostic applications.
    Zhu JH; Xu GX; Shum J; Lee LC; Lo KK
    Chem Commun (Camb); 2021 Nov; 57(90):12008-12011. PubMed ID: 34709253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-ray tomography of cryopreserved human prostate cancer cells: mitochondrial targeting by an organoiridium photosensitiser.
    Bolitho EM; Sanchez-Cano C; Huang H; Hands-Portman I; Spink M; Quinn PD; Harkiolaki M; Sadler PJ
    J Biol Inorg Chem; 2020 Mar; 25(2):295-303. PubMed ID: 32124100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.